Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Cardiac amyloidosis has a wide spectrum of clinical manifestations but the ...

In a bid to revolutionize Alzheimer’s detection, scientists have examined the brain’s neurovascular unit. The research ...

Cardiac amyloidosis is a condition that occurs when abnormal proteins called "amyloid" build up in your heart. These proteins can develop and grow in the heart tissue, increasing your risk for ...

The trial is designed to determine the sensitivity and specificity of 124 I-evuzamitide imaging to diagnose cardiac amyloidosis. “This study seeks to add significant value for patient care ...

Life Molecular Imaging (LMI), an international pharmaceutical company dedicated to developing and offering novel cutting-edge PET radiopharmaceuticals for imaging, announces that the U.S. Food and ...

Findings from this collaboration have the potential to impact not only amyloidosis but also other cardiac conditions, where non-invasive, information-rich diagnosis and monitoring are crucial.

Endomyocardial biopsy is the only method by which the presence of cardiac amyloidosis can be directly established in cardiac amyloidosis, but this method is invasive, expensive and not always ...

124 I-evuzamitide has received Breakthrough Therapy Designation from the Food and Drug Administration (FDA) for PET imaging in patients with suspected or known cardiac amyloidosis. 124 I ...